DISCUS DENTAL HELPS RAISE OVER $1.3 MILLION
Company Continues a 13-Year Tradition of Support of the Smile For Life program Culver City, CA, October 7, 2010 – Discus Dental LLC has announced
Company Continues a 13-Year Tradition of Support of the Smile For Life program Culver City, CA, October 7, 2010 – Discus Dental LLC has announced
GC America’s Glass Ionomer Sealants don’t Contain Bis-GMA or BPAUse GC Fuji TRIAGE® Glass Ionomer Sealant and Surface Protectant for Caries Prevention September 2010 –
The South Dakota Board of Dentistry is proposing to amend rules regarding sedation and advertising, according to the Academy of General Dentistry. The proposal would
Body Dentistry is evolving. Our success, as a profession and as practitioners, depends on adapting to the challenges and changes that lie ahead. First, however,
NEW YORK (Reuters Health) – Early treatment of obstructive apnea (OSA) with nasal continuous positive airway pressure (nCPAP) may speed recovery from ischemic stroke, researchers
August 2010 – Research presented at the 2010 International Association for Dental Research meeting in Barcelona, Spain supports the use of MI Paste Plus™ with
A Liverpool dental practice is taking a fresh approach to dentistry. Milk: Fresher Dentistry forms part of a wider strategy of owner and practice principal,
Body Dr. John O’Keefe JCDA is embracing multimedia communication and I believe the JCDA clinical article of the future is as likely to be “shot”
Lying appears to create a desire for mouthwash, according to researchers from the University of Michigan (Psychological Science, September 7, 2010). “The references to ‘dirty
Anesthesia Progress – A wide variation has been found in the training for and practice of sedation and general anesthesia within the dental profession in
The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, used $101.8 million in American Recovery and Reinvestment Act funds
A New Jersey jury ruled October 6 that Novartis provided adequate warnings about the risk of its bisphosphonate drugs, rejecting a lawsuit by a woman